Innovation Licensing Agreement with Harmonic Discovery and UCSF for FLT3 Mutated AML Development Program BioVentures has announced a licensing agreement with Harmonic Discovery and UC San Francisco for the development of a new drug Read More » February 5, 2024
Innovation New Opportunity to Accelerate Innovative Technologies The BioVentures Development Award Program is a new funding mechanism designed to accelerate the pace of the development of highly innovative technologies and entrepreneurship activity at the University of Arkansas for Medical Sciences (UAMS). Read More » November 16, 2022